Company profileCore BCI
ABILITY Neurotech
A fully implanted ECoG system that sends raw neural data through the skin by infrared light.
- Location
- Geneva, Switzerland
- Founded
- 2025
- Class
- Core BCI
- Also known as
- ABILITY · Ability Neurotech
- Website
- abilityneuro.com
- Sources last checked
- 4 Oct 2026
What they are building
Geneva spin-out of the Wyss Center developing a battery-free implant with 128-channel surface arrays and an optical data link, aimed first at restoring communication.
- Interface category
- Electrocorticography
- Signal
- Local field potentials, including high-gamma activity
- Invasiveness
- Invasive
- Recording / stimulation
- Recording
- Device
- ABILITY system — Battery-free implant with surface electrode arrays and an infrared optical data link through the skin
- Channels
- 128-channel arrays
- Regulatory status
- Investigational; intraoperative use reported, chronic study planned
- Main use cases
- Communicate, Control
- Works with
- Wyss Center for Bio and Neuroengineering · UMC Utrecht · Graz University of Technology
Where they are clinically
First-in-human
The first use of a device in a small number of people, focused on safety.
Human use so far is intraoperative and brief. The first chronic implant study has ethics approval in the Netherlands and had not begun as of August 2026.
Access today
Experimental human research
Demonstrated in a small number of research participants. Not an established treatment.
- Shown in people
- Brief recordings during surgery in Germany. The 50 megabit per second optical link and the 128-channel arrays are design figures.
- Still an aim
- A one-year home-use study in people with ALS at UMC Utrecht, planned for late 2026.
- What stands in the way
- Chronic performance: how an optical link through skin behaves over months of daily use.
On record here: 0 peer-reviewed papers
This technology remains experimental and is not an established treatment. Access is limited to registered clinical studies.
Why this company matters
ABILITY is the most concrete European answer to the question of how to get high-bandwidth data out of a sealed implant: light, not radio, at a reported 50 megabits per second, with no battery inside the head. Its first chronic study is planned at the centre that ran the longest home-use ECoG implant on record. Until that study reports, the performance of the link in daily life is a design claim.
Key milestones
20 Aug 2026
Intraoperative study under way in Germany. A one-year home-use study in people with ALS is planned for late 2026 at UMC Utrecht, with TU Graz and CorTec as partners; the company says a Dutch ethics committee has approved the device dossier.
2025
Spun out of the Wyss Center for Bio and Neuroengineering in Geneva.
Leadership
Rotem Kopel
CEO
As publicly stated by the organisation. Not a complete list.
Competitive context
ECoGFirst-in-human
CorTec
A fully implanted closed-loop system that both records from and stimulates the cortical surface.
ECoGApproved / cleared
Precision Neuroscience
A thin-film cortical surface array that slides under the skull through a narrow slit.
EndovascularFeasibility
Synchron
A BCI delivered through the blood vessels, without open brain surgery.
ECoGFirst-in-human
Neurosoft Bioelectronics
Soft, stretchable electrode arrays for the brain surface, tested during surgery in people.
Latest BCI Briefing coverage
Clinical · 20 Aug 2026
A European implant sends brain data out by light
Sources
- 01
Ability Neurotech Infrared BCI to Begin Human Trials (opens in a new tab)
Independent reportingIEEE Spectrum20 Aug 2026Checked against source 4 Oct 2026
Reports the intraoperative study, the planned Utrecht study, the device specifications and an outside researcher's caution about long-term performance.
- 02
ABILITY Neurotech Receives Approval to Start Clinical Trial (opens in a new tab)
Company reportedWyss Center for Bio and NeuroengineeringChecked against source 4 Oct 2026
Announcement by the institute the company was spun out of. The page carries no date.